Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU

Comparison of expression vectors in Lactobacillus reuteri  strains

(2010) Michela Lizier et al.   FEMS MICROBIOLOGY LETTERS

Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase

(2010) Ilaria Roato et al.   PLoS One

Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response

(2009) Megan Livingston et al.   IMMUNOLOGY AND CELL BIOLOGY

Converting an injectable protein therapeutic into an oral form: Phenylalanine ammonia lyase for phenylketonuria

(2009) Tse Siang Kang et al.   MOLECULAR GENETICS AND METABOLISM

Psychiatric symptoms and disorders in phenylketonuria☆

(2009) V.L. Brumm et al.   MOLECULAR GENETICS AND METABOLISM

Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria

(2008) F. Porta et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria

(2008) C. N. Sarkissian et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA